4 red flags – and 1 truth
Unregulated peptide hype meets alarming health reports and a puzzling pharma link, prompting a four‑flag warning list.
28 trends tracked about this subject — the full history, oldest to newest below.
Unregulated peptide hype meets alarming health reports and a puzzling pharma link, prompting a four‑flag warning list.
Peptides are rapidly gaining widespread visibility, prompting medical professionals to issue cautionary guidance to consumers.
The Trump administration advances a policy initiative regarding peptide drugs, drawing widespread attention across multiple news outlets.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Concerns are rising in Beverly Hills over the proliferation of peptide injections and the lack of transparency regarding their composition.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
American teenagers are increasingly utilizing peptides and injections in a pursuit of perfected physical aesthetics known as looksmaxxing.
NPR examines the regulatory and commercial hurdles involved in bringing peptide-based products to retail shelves.
An FDA advisory panel has signaled support for easing restrictions on six specific peptides for compounding, sparking a debate over drug safety.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
An FDA panel's narrow vote backing four controversial peptides sparks rising concern over a potential prescribing boom.
FDA advisers have narrowly voted to add six controversial peptides to a drug compounding list, signaling a shift in regulatory access.
FDA advisers vote to loosen rules on poorly understood peptides, sparking talk of a biotech gold rush.
An FDA advisory panel has voted to add unproven peptides to a permitted list, sparking a conflict between advisers and agency scientists.
An FDA advisory panel has voted to allow the compounding of unapproved peptides, signaling a potential conflict with agency scientists.
The FDA is reviewing restrictions on seven popular peptide injections, sparking a potential conflict between federal scientists and political agendas.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A pending FDA advisory panel vote on seven specific peptides could unlock a multibillion-dollar market for telehealth and longevity medicine.
Federal regulators face mounting scrutiny over potential conflicts of interest ahead of an upcoming vote on peptide substances.
FDA’s new peptide panel sparks regulatory debate as biotech giants Lilly and Novo eye the next health wave.
Growing public curiosity surrounds peptides as they emerge in discussions regarding skincare, male vitality, and general health benefits.
Peptides surge into spotlight, from hair‑loss hopes to black‑market debates and a new U.S. fentanyl link.
Medical experts and health organizations are raising alarms over the resurgence of an illicit tanning peptide often referred to as the Barbie drug.
Peptide therapy has emerged as a major wellness trend, sparking concerns over the safety and regulatory status of products in a rapidly growing market.